FDA greenlights marketing of first Alzheimer's blood test for some patients

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of cognitive decline.

from Us - CBSNews.com https://ift.tt/rEBTuVP
via IFTTT